Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse ...

FINRA has published the 2025 FINRA Regulatory Oversight Report—a vital information resource comprising observations from across FINRA’s Member Supervision, Market Regulation and Enforcement programs ...

The report reflects FINRA’s commitment to providing transparency to member firms and the investing public about its regulatory observations and activities. This press release features multimedia.

The Swiss bank UBS has examined the sentiments of entrepreneurs worldwide and compiled a detailed report for the first time.

The Cyprus Securities and Exchange Commission (CySEC) on Friday hosted an online event to Alternative Investments Funds Managers (AIFMs). The event focused on the technical and regulatory aspects of ...

Speaking on a results’ briefing Flex LNG Management chief executive Oystein Kalleklev said 95% of trading in Flex stock ...

Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, invites to a webcast presentation of its fourth quarter 2024 results, ...

Ørsted A/S (Orsted) Ørsted to present its annual report for 2024 on February 6 30-Jan-2025 / 17:04 CET/CEST 30.1.2025 17:04:45 CET | Ørsted A/S | Investor News ...

Australian regulator consults for regulatory guidance on sustainability reporting The consultation paper outlines the Australian Securities and Investment Commission (ASIC)’s approach to ...

published the 2025 update to its annual Regulatory Oversight Report. 1 The report collects recent observations and findings from FINRA's oversight programs – Member Supervision, Market ...

The presentation is open to all existing and potential shareholders. Questions can be submitted before the event via the Investor Meet Company dashboard up until 9:00am GMT on Wednesday ...